FLT3-IN-17 inhibits CYPs and FLT3 mutants activity (IC50s: <0.5 nM for D835Y). FLT3-IN-17 is also a FAK inhibitor, with an IC50 value of 12 nM. FLT3 ligand-2 can be used in the research of cancers.
FLT3-IN-17 (compound 25, 72 h) inhibits cell growth in HCT-116, MDA-MB-231, A375 cells[1].FLT3-IN-17 (10 μM) inhibits cytochrome P450s (CYPs) with inhibition rates >55%[1].FLT3-IN-17 inhibits FLT3 mutants activity (IC50s: <0.5 nM for D835Y, 1.6-183 nM for Ba/F3)[1].
References:
[1]. Hanna Cho, et al. Identification of Thieno[3,2- d]pyrimidine Derivatives as Dual Inhibitors of Focal Adhesion Kinase and FMS-like Tyrosine Kinase 3. J Med Chem. 2021 Aug 26;64(16):11934-11957.